Cellectar Biosciences Inc. (CLRB)
Cellectar Biosciences Reports Second Quarter 2026 Financial Results and Provides Corporate Updates
CELLECTAR BIOSCIENCES, INC. (CLRB)
Cellectar Biosciences Reports Second Quarter 2026 Financial Results and Provides Corporate Updates
SES AI CORP (SES)
SES AI Appoints Paul Diemer to Board of Directors
ARCOS DORADOS HOLDINGS INC. (ARCO)
Arcos Dorados Reports Second Quarter 2026 Financial Results
MOBIX LABS, INC (MOBX)
Mobix Labs Signs Definitive Rare Earth Elements Deal, Expanding National Security Platform; Hosts Investor Call Today at 4:15pm ET
LIMINATUS PHARMA, INC. (LIMN)
Liminatus Pharma Announces Transfer to Nasdaq Capital Market and Extension to Regain Compliance with Minimum Bid Price Requirement
CALIBERCOS INC. (CWD)
Caliber Goes Live with PURE Pickleball & Padel Tokenized Real Estate Investment Offering
HYPHENS PHARMA INTERNATIONAL LIMITED (1J5)
Financial Statements and Related Announcement: Half Yearly Results
Hyphens Pharma International Limited (1J5)
Financial Statements and Related Announcement: Half Yearly Results (2026)
PELTHOS THERAPEUTICS INC. (PTHS)
Pelthos Therapeutics Announces Second Quarter 2026 Financial Results